[Corrigendum] RNA‑binding protein CELF2 inhibits breast cancer cell invasion and angiogenesis by downregulating NFATc1

Zhou,Limin; Xie,Xiju

doi:10.3892/etm.2022.11170

March-2022 Volume 23 Issue 3

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

March-2022 Volume 23 Issue 3

Full Size Image

Correction Open Access

[Corrigendum] RNA‑binding protein CELF2 inhibits breast cancer cell invasion and angiogenesis by downregulating NFATc1

Authors:
- Limin Zhou
- Xiju Xie
View Affiliations / Copyright

Affiliations: Department of The Second Section Office of Breast Tumor, Jilin Cancer Hospital, Changchun, Jilin 130000, P.R. China, Department of Breast Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China

Copyright: © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article Number: 245
|
Published online on: January 27, 2022

https://doi.org/10.3892/etm.2022.11170
Expand metrics +

Article

Exp Ther Med 22:[Related article:] Article no. 898, 2021; DOI: 10.3892/etm.2021.10330

Subsequently to the publication of the above article, an interested reader drew to the authors’ attention that an error was made during the compilation of Fig. 2. Specifically, in Fig. 2A, the same image for the mice (accurately presented for the ‘OverExp-CELF2’ experiment) was inadverently chosen to also represent the ‘Con’ experiment.

Figure 2

CELF2 overexpression inhibits tumor growth and angiogenesis. (A) Mice and tumor in the three groups. (B) Mouse weight changed from day 0 to day 21. ***P<0.001 vs. Con group. ##P<0.01 and ###P<0.001 vs. NC group. (C) Tumor volume changed from day 0 to day 21. **P<0.01 and ***P<0.001 vs. Con group. #P<0.05 and ###P<0.001 vs. NC group. (D) Tumor weight at day 21. ***P<0.001 vs. Con group. ###P<0.001 vs. NC group. (E) Tumor volume at day 21. ***P<0.001 vs. Con group. ###P<0.001 vs. NC group. (F) Angiogenesis was analyzed by HUVEC tube formation assay; scale bar, 100 µm. (G) Western blot analysis was performed to detect the expression of proteins associated with invasion and angiogenesis and NFATc1 in tumor tissues. **P<0.01 and ***P<0.001 vs. Con group. ##P<0.01 and ###P<0.001 vs. NC group. CELF2, CUGBP Elav-like family member 2; NFATc1, nuclear factor of activated T cells 1; Con, control; NC, negative control.

The authors have re-examined their raw data and identified the data that should have been included in the figure. The corrected version of Fig. 2 is shown on the next page, now including the correct data for the ‘Con’ experiment in Fig. 2A. Note that this error did not have a major impact on either the overall results or on the conclusions reported in this study. The authors regret the error that was made during the assembly of Fig. 2, and apologize to the readership for any inconvenience caused.

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

[Corrigendum] RNA‑binding protein CELF2 inhibits breast cancer cell invasion and angiogenesis by downregulating NFATc1

This article is mentioned in:

Article

Figure 2

Related Articles